Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice

Journal of Orthopaedic Research

Volumn 31, Issue 11, 2013, Pages 1845-1850

  Heilmann, Aline ^a   Schinke, Thorsten ^b   Bindl, Ronny ^a   Wehner, Tim ^a   Rapp, Anna ^a   Haffner Luntzer, Melanie ^a   Liedert, Astrid ^a   Amling, Michael ^b   Ignatius, Anita ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

fracture healing; FTY720; sphingosine 1 phosphate

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; FINGOLIMOD; METHACRYLIC ACID METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE REGENERATION; BONE REMODELING; CALLUS; CONTROLLED STUDY; EXTERNAL FIXATOR; FRACTURE HEALING; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SYSTEMIC THERAPY;

FRACTURE HEALING; FTY720; SPHINGOSINE-1-PHOSPHATE;

ACID PHOSPHATASE; ANIMALS; BIOMECHANICAL PHENOMENA; BONE REGENERATION; FEMALE; FRACTURE HEALING; MICE; MICE, INBRED C57BL; OSTEOCLASTS; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 84884901062     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22426     Document Type: Article

References (32)

1. Boyce BF, Xing L,. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473: 139-146.
2. Teitelbaum SL, Ross FP,. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649.
3. Boyce BF,. 2009. Sphingosine-1 phosphate: a new player in osteoimmunology. Dev Cell 16: 323-324.
4. Kollet O, Dar A, Lapidot T,. 2007. The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol 25: 51-69.
5. Spiegel S, Milstien S,. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407.
6. Spiegel S, Milstien S,. 2011. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11: 403-415.
7. Ryu J, Kim HJ, Chang EJ, et al. 2006. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25: 5840-5851.
8. Ishii M, Egen JG, Klauschen F, et al. 2009. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458: 524-528.
9. Ishii M, Kikuta J,. 2013. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim Biophys Acta 1831: 223-227.
10. Pederson L, Ruan M, Westendorf JJ, et al. 2008. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci USA 105: 20764-20769.
11. Sato C, Iwasaki T, Kitano S, et al. 2012. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. Biochem Biophys Res Commun 423: 200-205.
12. Lotinun S, Kiviranta R, Matsubara T, et al. 2013. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest 123: 666-681.
13. Matsuzaki E, Hiratsuka S, Hamachi T, et al. 2013. Sphingosine-1-phosphate promotes the nuclear translocation of beta-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. Bone 55: 315-324.
14. Brinkmann V,. 2009. FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158: 1173-1182.
15. Brinkmann V, Billich A, Baumruker T, et al. 2010. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9: 883-897.
16. Huang C, Das A, Barker D, et al. 2012. Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation. Cell Tissue Res 347: 553-566.
17. Petrie Aronin CE, Sefcik LS, Tholpady SS, et al. 2010. FTY720 promotes local microvascular network formation and regeneration of cranial bone defects. Tissue Eng Part A 16: 1801-1809.
18. Petrie Aronin CE, Shin SJ, Naden KB, et al. 2010. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. Biomaterials 31: 6417-6424.
19. Röntgen V, Blakytny R, Matthys R, et al. 2010. Fracture healing in mice under controlled rigid and flexible conditions using an adjustable external fixator. J Orthop Res 28: 1456-1462.
20. Morgan EF, Mason ZD, Chien KB, et al. 2009. Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone 44: 335-344.
21. Recknagel S, Bindl R, Brochhausen C, et al. 2013. Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus. J Trauma Acute Care Surg 74: 531-537.
22. Sefcik LS, Aronin CE, Awojoodu AO, et al. 2011. Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth. Tissue Eng Part A 17: 617-629.
23. Wamhoff BR, Lynch KR, Macdonald TL, et al. 2008. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 28: 1454-1461.
24. Schell H, Lienau J, Epari DR, et al. 2006. Osteoclastic activity begins early and increases over the course of bone healing. Bone 38: 547-554.
25. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. 2003. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
26. Kakar S, Einhorn TA, Vora S, et al. 2007. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903-1912.
27. Histing T, Marciniak K, Scheuer C, et al. 2011. Sildenafil accelerates fracture healing in mice. J Orthop Res 29: 867-873.
28. Kumagai K, Takeuchi R, Ishikawa H, et al. 2012. Low-intensity pulsed ultrasound accelerates fracture healing by stimulation of recruitment of both local and circulating osteogenic progenitors. J Orthop Res 30: 1516-1521.
29. Beil FT, Barvencik F, Gebauer M, et al. 2010. Effects of estrogen on fracture healing in mice. J Trauma 69: 1259-1265.
30. Claes L, Recknagel S, Ignatius A,. 2012. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 8: 133-143.
31. Nam D, Mau E, Wang Y, et al. 2012. T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS One 7: e40044.
32. Toben D, Schroeder I, El Khassawna T, et al. 2011. Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Mine Res 26: 113-124.